S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY

• Melina Sophie Kurte,
• Ann-Cathrine Siefen,
• Anna Marie Bauer,
• Hans Christian Reinhardt,
• Florian Kron

Affiliations

Melina Sophie Kurte

1 University of Duisburg-Essen, Faculty of Medicine, Essen, Germany

Ann-Cathrine Siefen

2 VITIS Healthcare Group, Cologne, Germany

Anna Marie Bauer

2 VITIS Healthcare Group, Cologne, Germany

Hans Christian Reinhardt

1 University of Duisburg-Essen, Faculty of Medicine, Essen, Germany

Florian Kron

2 VITIS Healthcare Group, Cologne, Germany